Expression of vascular endothelial growth factor and its receptors after mandibular distraction osteogenesis.
During distraction osteogenesis, angiogenic activity is essential for new bone formation. This study examined the expression of vascular endothelial growth factor (VEGF) and two of its receptors, Flt-1 (VEGFR-1) and Flk-1 (VEGFR-2), in cellular components after mandibular distraction osteogenesis. Unilateral mandibular distraction (0.5 mm twice per day for 10 days) was performed in six mongrel dogs. Two animals each were killed on days 7, 14 and 28 after completion of distraction. The distracted mandibular segments and contralateral undistracted control segments were harvested and processed for immunohistochemical examination. Seven days after distraction, there was a significant increase in the expression levels of VEGF and its receptors in the osteoblasts, osteocytes and immature fibroblast-like cells compared to control specimens. These levels were maintained for 14 days after distraction in the osteoblasts and fibroblast-like cells. Twenty-eight days after distraction, VEGF and VEGFR-1 were expressed only moderately/weakly in the osteoblasts, and no VEGFR-2 expression was detected in the cellular component of the distracted bone. Throughout the observation period, VEGFR-1 expression was stronger than that of VEGFR-2. The expression patterns of VEGF and its receptors suggest that it plays an important role in osteogenesis, and that osteoblasts and immature fibroblast-like cells of the distracted bone may have an autocrine growth effect during distraction osteogenesis.
Byun
J-H
JH
Department of Oral & Maxillofacial Surgery, College of Medicine and Institute of Health Sciences, Gyeongsang National University, Chilam-dong 90, Jinju-city, Gyeongnam, Republic of Korea.
Park
B-W
BW
Kim
J-R
JR
Lee
J-H
JH
D000818:Animals; D019898:Autocrine Communication / Q000502:physiology; D004396:Coloring Agents; D004285:Dogs; D005347:Fibroblasts / Q000378:metabolism; D007150:Immunohistochemistry; D008334:Mandible / Q000166:cytology / Q000378:metabolism / Q000601:surgery*; D023421:Models, Animal; D018919:Neovascularization, Physiologic / Q000502:physiology; D010006:Osteoblasts / Q000378:metabolism; D010011:Osteocytes / Q000378:metabolism; D010012:Osteogenesis / Q000502:physiology; D019857:Osteogenesis, Distraction; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000032:analysis*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000032:analysis*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000032:analysis*
D004396:Coloring Agents; D042461:Vascular Endothelial Growth Factor A; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2